Form 4: Amneal Pharmaceuticals Executive Sells 43,657 Shares

Amneal Pharmaceuticals' SVP, Chief Legal Officer, Jason B. Daly, sold 43,657 shares of Class A Common Stock at a weighted average price of $8.61.

Summary

• Jason B. Daly, SVP and Chief Legal Officer at Amneal Pharmaceuticals, sold 43,657 shares of Class A Common Stock.
• The sale occurred on November 15, 2024.
• The shares were sold at a weighted average price of $8.61 per share.
• The prices ranged from $8.50 to $9.00 per share.
• Following the transaction, Mr. Daly directly owns 13,665 shares.

Sentiment

Score: 5

Explanation: The document is a neutral report of an insider stock sale, which is a common occurrence and does not inherently indicate positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is common when company insiders trade shares. It is a normal part of the market and does not necessarily indicate a change in the company's outlook.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider trading activity.
• There are no specific industry benchmarks to compare this transaction to, as it is an individual executive's sale of shares.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on shareholder sentiment, but it is not expected to have a significant impact on the company's operations or financial health.

Key Dates

Keywords

Amneal Pharmaceuticals, insider trading, stock sale, executive, AMRX, Class A Common Stock, Jason B. Daly